198 related articles for article (PubMed ID: 3906131)
1. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
2. Design of potent substrate-analogue inhibitors of canine renin.
Hui KY; Siragy HM; Haber E
Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
[TBL] [Abstract][Full Text] [Related]
3. Design of rat renin inhibitory peptides.
Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
[TBL] [Abstract][Full Text] [Related]
4. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
[TBL] [Abstract][Full Text] [Related]
6. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
Hui KY; Carlson WD; Bernatowicz MS; Haber E
J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs.
Smith SG; Seymour AA; Mazack EK; Boger J; Blaine EH
Hypertension; 1987 Feb; 9(2):150-6. PubMed ID: 3028953
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mouse submaxillary gland renin with a statine-containing, subnanomolar, competitive inhibitor.
Poe M; Perlow DS; Boger J
J Enzyme Inhib; 1985; 1(1):13-23. PubMed ID: 3916910
[TBL] [Abstract][Full Text] [Related]
9. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.
Bock MG; DiPardo RM; Evans BE; Freidinger RM; Rittle KE; Payne LS; Boger J; Whitter WL; LaMont BI; Ulm EH
J Med Chem; 1988 Oct; 31(10):1918-23. PubMed ID: 3050088
[TBL] [Abstract][Full Text] [Related]
11. New potential renin inhibitors with dipeptide replacements in the molecule.
Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R
Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
13. Statine-containing dipeptide and tripeptide inhibitors of human renin.
Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and biological activities of renin inhibitors containing statine analogues.
Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
Paruszewski R; Tautt J; Dudkiewicz J
Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
Rich DH; Sun ET; Ulm E
J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
Maibaum J; Rich DH
J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
[TBL] [Abstract][Full Text] [Related]
18. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives.
Roberts DA; Bradbury RH; Brown D; Faull A; Griffiths D; Major JS; Oldham AA; Pearce RJ; Ratcliffe AH; Revill J
J Med Chem; 1990 Sep; 33(9):2326-34. PubMed ID: 2118183
[TBL] [Abstract][Full Text] [Related]
19. Novel renin inhibitors containing the amino acid statine.
Boger J; Lohr NS; Ulm EH; Poe M; Blaine EH; Fanelli GM; Lin TY; Payne LS; Schorn TW; LaMont BI; Vassil TC; Stabilito II; Veber DF; Rich DH; Bopari AS
Nature; 1983 May 5-11; 303(5912):81-4. PubMed ID: 6341856
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of human renin by statine-containing tripeptide renin inhibitor (ES-1005).
Kokubu T; Hiwada K; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S88-90. PubMed ID: 2485069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
